Hence, the relative potential adverse influence of circulating adiponectin on blood pressure may be counterbalanced by its beneficial impact on lipid metabolism, thereby resulting in an overall neutral effect on atherosclerosis in RA. The gene discussed is ADIPOQ; the disease is atherosclerosis.